Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products
1 other identifier
interventional
24
1 country
1
Brief Summary
This study aimed at determining the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products in two different ethnic groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 30, 2015
CompletedFirst Posted
Study publicly available on registry
January 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedSeptember 14, 2017
September 1, 2017
5 months
October 30, 2015
September 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glycaemic index values of five cereal products
Determination of GI in both Caucasian and Asian subjects
2 hours after food consumption
Secondary Outcomes (15)
Glycaemic response assessed by the glycemic index (GI) values of five cereal products
2 hours after food consumption
Glycaemic response assessed by the postprandial changes in glycaemia over 2 hours (iAUC0-120) after consumption of the test products
2 hours after food consumption
Glycaemic response assessed by the kinetic of glycemia over the 120 minutes
2 hours after food consumption
Glycaemic response assessed by the peak value of glycemia
2 hours after food consumption
Glycaemic response assessed by the delta value between baseline and peak values of glycemia
2 hours after food consumption
- +10 more secondary outcomes
Study Arms (6)
Product A: NP-0148
EXPERIMENTALCereal product belVita Milk \& Cereals - High in SDS
Product B: NP-0149
EXPERIMENTALCereal product belVita Honey \& Nuts - High in SDS
Product C: NP-0150
EXPERIMENTALCereal product belVita Mixed Berry - High in SDS
Product D: NP-0151
EXPERIMENTALCereal product Kellogg's Corn Flakes - Low in SDS - Low in fat
Product E: NP-0152
EXPERIMENTALCereal product Kellogg's Trésor Duo Choco - Low in SDS
Glucose reference
EXPERIMENTALGlucose solution performed on three occasions
Interventions
Portions of cereal product calculated to provide 50 g of available carbohydrates will be served with 250 mL water.
Glucose solution providing 50 g of available carbohydrates in 250 ml of water. This will be performed 3 times
Portions of cereal product calculated to provide 50 g of available carbohydrates will be served with 250 mL water.
Portions of cereal product calculated to provide 50 g of available carbohydrates will be served with 250 mL water.
Portions of cereal product calculated to provide 50 g of available carbohydrates will be served with 250 mL water.
Portions of cereal product calculated to provide 50 g of available carbohydrates will be served with 250 mL water.
Eligibility Criteria
You may qualify if:
- Aged between 18-45 years.
- Non-smoker.
- BMI values: between 19-25 kg/m2 (bounds included) for Caucasian subjects and between 19-23 kg/m2 (bounds included) for Asian subjects (WHO expert consultation).
- Ethnicity: Caucasian subjects will have both parents from Caucasian ancestry. Asian subjects will have both parents from Asian country and will be born in an Asian country. Asian countries are: Brunei Darussalam, Cambodia, China, Dem. People's Republic of Korea, Hong Kong SAR (China), Indonesia, Japan, Lao People's Democratic Republic, Macao SAR (China), Malaysia, Mongolia, Myanmar, Philippines, Republic of Korea, Singapore, Taiwan, Thailand, Viet Nam.
- Sex ratio: Around half of the subjects should be male and half of the subjects should be female within each study group. A plus or minus 1 subject tolerance will be accepted.
- Healthy subjects with:
- Normal glucose tolerance Normal laboratory values for various measures of metabolic health (full blood count, gamma-GT, AST, ALT, glucose, TAGs, total cholesterol, HDL-cholesterol, LDL-cholesterol); Normal systolic blood pressure (100-150 mmHg); Normal diastolic blood pressure (60-90 mmHg); Normal resting heart rate (50-90 beats per minutes after 3 minutes rest).
- Stable dietary habits; normal eating patterns; no history of eating disorders or strict dieting.
- Moderate level of physical activity (from basic daily activity to a high level of physical activity (regular physical activity at least 3 times per week))
- Able to fast for at least 10 hours the night before each test session.
- Able to refrain from eating legumes and drinking alcohol the day before each test session.
- Subject covered by social security or covered by a similar system
- Subject not taking any treatment for anorexia, weight loss, or any form of treatment likely to interfere with metabolism or dietary habits
- Subject having given written consent to take part in the study.
You may not qualify if:
- Following a restrictive diet.
- Family history of Diabetes Mellitus or obesity
- Suffering from any clinical, physical or mental illness.
- Suffering from any food allergies or hypersensitivities (wheat, milk, egg, nuts, etc).
- Female who is pregnant (positive test results), lactating, planning pregnancy or not using acceptable contraceptive.
- Females who consistently suffer from premenstrual tension and marked changes in appetite during their menstrual cycle.
- Subject having taken part in another clinical trial within the last week.
- Subject in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mondelēz International, Inc.lead
- University of Sydneycollaborator
Study Sites (1)
University of Sydney
Sydney, New South Wales, 2006, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennie Brand Miller
University of Sydney
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2015
First Posted
January 8, 2016
Study Start
October 1, 2015
Primary Completion
March 1, 2016
Study Completion
April 1, 2016
Last Updated
September 14, 2017
Record last verified: 2017-09